------------------------------
OMB APPROVAL
------------
OMB Number: 3235-0058
UNITED STATES Expires: May 31, 1997
SECURITIES AND EXCHANGE COMMISSION Estimated average burden
Washington, D.C. 20549 hours per response......2.50
------------------------------
FORM 12b-25 ------------------------------
SEC FILE NUMBER
0-11476
NOTIFICATION OF LATE FILING ------------------------------
------------------------------
CUSIP NUMBER
(Check One): [_] Form 10-K [_] Form 20-F [_] Form 11-K 422214-60-1
[X] Form 10-Q [_] Form N-SAR ------------------------------
For Period Ended: March 31, 2002
--------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: __________________________________
-------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
================================================================================
Full Name of Registrant
HealthWatch, Inc
--------------------------------------------------------------------------------
Former Name if Applicable
--------------------------------------------------------------------------------
Address of Principle Executive Office (Street and Number)
1100 Johnson Ferry Road, Suite 670
--------------------------------------------------------------------------------
City, State and Zip Code
Atlanta, Georgia 30342
--------------------------------------------------------------------------------
Part II -- RULES 12b25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable
| effort or expense;
| (b) The subject annual report, semi-annual report, transition
| report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
| portion thereof, will be filed on or before the fifteenth
[X] | calendar day following the prescribed due date; or the
| subject quarterly report of transition report on Form
| 10-Q, or portion thereof will be filed on or before the
| fifth calendar day following the prescribed due date; and
|
| (c) The accountant's statement or other exhibit required by
| Rule 12b-25(c) has been attached if applicable.
SEC 1344 (6/94)
Part III -- NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 11-K, 10-Q, N-SAR,
or the transition report or portion thereof, could not be filed within the
prescribed time period.
The Company has not been able to complete the final review of its
financial statements in a timely manner without unreasonable efforts
and expense. Due to resource constraints, the Company will be unable
to complete its review of final adjustments by the filing due date.
Additional time is necessary for management to assure itself that all
adjustments and efforts have been made to file with the Commission
correct financial statements for this period.
Part IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Thomas C. Ridenour, CFO (404) 256-0083
---------------------------- -------------- ------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If answer is no, identify report(s). [X] Yes [_] No
--------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last year will be reflected by
the earnings statements to be included in the subject report or
portion thereof? [X] Yes [_] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
--------------------------------------------------------------------------------
HealthWatch, Inc
-----------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date May 14,2002 By: /s/ Thomas C. Ridenour, Chief Financial Officer
-------------- -----------------------------------------------
[Type in Name]
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
--------------------------------------------------------------------------------
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
--------------------------------------------------------------------------------
HealthWatch, Inc.
EXPLANATION
Form 12b-25
Part IV (3) - Other Information
o Significant reduction in operating expenses and net loss.